After successfully completing initial safety and feasibility trials, Quietmind Foundation, in cooperation with Texas A&M and Baylor Research Institute, enrolled 100 adults (50-85) with memory loss for a new innovative clinical study. This study recently completed data collection and reports are being prepared with reportedly very encouraging preliminary results.
About The Clinical Trial
In cooperation with Texas A&M University's Dept. of Neurosurgery, Quietmind Foundation enrolled individuals age 50-85 years experiencing memory problems and who had been independently diagnosed with early to mid-stage dementia to participate in this trial. The study used low-level infrared light stimulation directed to the head. The stimulation sessions were conducted at home, twice daily, for 5 minutes over 60 consecutive days. The trial was randomized, placebo controlled and double blinded.
Individuals that matched the clinical trial eligibility criteria went through two unique assessments at the start, mid-point, and ending of the trial period.
Participants repeated the EEG and cognitive assessments twice more during the two month trial.